SHANGHAI and CAMBRIDGE, Mass, Nov. 14, 2026 /PRNewswire/ -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), an innovation-driven, global biopharma company, today announced that five of its commercial medicines in China have been included in the country's 2026 National Reimbursement Drug List (NRDL). The update includes two first-time listings,...
LAS VEGAS, Jan. 16, 2026 /PRNewswire/ -- AGIBOT, a leading robotics company specializing in embodied intelligence, today marked its official entry into the U.S....
SHENZHEN, China, Jan. 15, 2026 /PRNewswire/ -- BOSGAME, a technology-based electronic product brand, has officially announced the launch of two new AI PC models,...
TAIPEI, Jan. 16, 2026 /PRNewswire/ -- To accelerate the co-development of Taiwan–U.S. startup ecosystems in artificial intelligence (AI), semiconductors, and advanced technologies, Startup Island...
ZYT's German Office Commences Operations in January, Debuting Local Recruitment for European Push SHENZHEN, China, Jan. 16, 2026 /PRNewswire/ -- Intelligent driving solution provider...